Aegera Therapeutics Revenue

Pharmaceutical Manufacturing • Montreal, Quebec, Canada • 1-10 Employees

Aegera Therapeutics revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,700,000
Total funding	$6,400,000

Key Contact at Aegera Therapeutics

Jon Durkin

Senior Vice President Research and Preclinical Development

Company overview

Headquarters	Montreal, Quebec, Canada
Phone number	+1514288553
Website	aegera.com
NAICS	3254
SIC	283
Employees	1-10
Socials

About Aegera Therapeutics

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Aegera Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Aegera Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2009-10-25	12	$6,400,000

Funding Insights

$6,400,000

Total funding amount

$6,400,000

Most recent funding amount

Number of funding rounds

Aegera Therapeutics Tech Stack

Discover the technologies and tools that power Aegera Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

HTTP/3

Miscellaneous

Frequently asked questions

Aegera Therapeutics is located in Montreal, Quebec, CA.

You can reach Aegera Therapeutics at +1514288553.

Aegera Therapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Aegera Therapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Aegera Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Aegera Therapeutics has raised a total of $6,400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Aegera Therapeutics

Jon Durkin

Senior Vice President Research and Preclinical Development

4.8

40,000 users